Albireo Pharma, Inc. (NASDAQ:ALBO)

About the company

Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. It pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

55

$11.00M

Total Revenue

55

Employees

$332.41M

Market Capitalization

-4.35

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-78M

Net Margin (in %)

Total net margin

$-80M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7525.41 4837.00 1.29 51.34 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5064.54 1443.00 1.76 9.77 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 2963.17 None 20.11 -32.94 None
Pacira Biosciences, Inc. PCRX 2275.14 435.00 6.10 -5417.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2054.48 335.00 4.72 19.36 31.64
Prestige Consumer Healthcare, Inc. PBH 1862.52 963.00 1.57 13.14 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1617.30 0.00 4.32 -15.83 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1595.90 440.00 -22.59 18.82 19.14
Revolution Medicines, Inc. RVMD 1567.34 48.00 4.07 -22.14 -146.29
Innoviva, Inc. INVA 1534.54 285.00 3.63 7.94 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1246.21 5.00 3.40 -2.93 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1136.58 88.00 -7.98 -4.61 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1053.50 327.00 2.63 20.67 15.90
Endo International Plc ENDP 777.48 3014.00 -1.06 -2.77 -9.09
BellRing Brands, Inc. BRBR 771.22 954.00 -0.42 5.85 13.98
Assembly Biosciences, Inc. ASMB 693.39 16.00 3.11 -6.97 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 641.70 79.00 5.09 -3.17 -252.92
Collegium Pharmaceutical, Inc. COLL 581.06 299.00 4.16 -44.97 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 537.14 119.00 5.23 12.24 36.09
Anika Therapeutics, Inc. ANIK 494.20 125.00 1.71 17.83 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 332.41 11.00 3.38 -4.35 -730.55
MEI Pharma, Inc. MEIP 284.69 5.00 4.90 -7.30 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 163.43 None 2.66 -7.91 None
Marinus Pharmaceuticals, Inc. MRNS 161.60 0.00 6.26 -2.40 None
Cerecor, Inc. CERC 120.75 7.00 7.72 -5.36 -429.22
Ampio Pharmaceuticals, Inc. AMPE 95.81 1.00 67.00 -5.15 None
CTI BioPharma Corp. CTIC 91.45 3.00 4.08 -2.21 -111.83
AcelRx Pharmaceuticals, Inc. ACRX 87.20 2.00 -1.60 -1.56 -644.25
Evoke Pharma, Inc. EVOK 86.88 None 30.17 -12.93 None
Zynerba Pharmaceuticals, Inc. ZYNE 74.75 0.00 1.23 -2.08 -699.94
Adamas Pharmaceuticals, Inc. ADMS 71.96 57.00 -4.59 -0.78 -160.44
Aclaris Therapeutics, Inc. ACRS 68.88 4.00 1.21 -0.50 None
Oramed Pharmaceuticals, Inc. ORMP 60.48 3.00 4.87 -4.73 -464.15
Cassava Sciences, Inc. SAVA 59.28 41.00 3.12 -13.00 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.65 47.00 1.01 -11.03 -9.59
SCYNEXIS, Inc. SCYX 48.95 0.00 10.28 -1.26 -30.84
Natural Alternatives International, Inc. NAII 47.11 114.00 0.65 -12.46 -3.19
IsoRay, Inc. ISR 42.88 9.00 8.00 -12.80 -36.08
Lipocine, Inc. LPCN 39.60 0.00 9.43 -2.64 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.00 0.00 -2.59 -2.86 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.24 3.00 2.39 -1.62 -264.21
Regulus Therapeutics, Inc. RGLS 18.15 0.00 1.60 -0.85 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.30 8.00 0.65 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.66 None 1.37 -0.25 None
VIVUS, Inc. VVUS 8.88 73.00 -0.20 -0.30 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.37 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.76 None 1.80 -0.48 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.27 None 1.07 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Souring On Albireo Pharma, Inc. (ALBO)

3d ago, source: YAHOO!

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of ...

Why Albireo Pharma (ALBO) Stock Might be a Great Pick

7d ago, source: Nasdaq

One stock that might be an intriguing choice for investors right now is Albireo Pharma, Inc. ALBO. This is because this ...

Albireo Pharma Inc.

7d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments

28d ago, source: MarketWatch

BOSTON, June 10, Jun 10, 2020 (GLOBE NEWSWIRE via COMTEX) -- BOSTON, June 10, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company ...

Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments

28d ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net BOSTON, June 10, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.